dayliyreport

Search

Bonds

Successful Bond Issuance Bolsters ADDvise Group's Financial Framework

·5 min read
Advertisement

Achieving a significant milestone, ADDvise Group AB has recently finalized the issuance of SEK 800 million in senior unsecured bonds. This issuance operates within a framework of SEK 1.6 billion and features a duration of 3.5 years. These newly issued bonds will be subject to a floating interest rate based on STIBOR 3m plus an annual percentage increase of 3.5%. The issuance is anticipated to settle by May 28, 2025, and it garnered substantial interest from both Nordic and international institutional investors.

The strategic decision to issue these bonds reflects the company’s commitment to enhancing its capital structure and ensuring long-term financial stability. Staffan Torstensson, CEO of ADDvise Group, expressed gratitude towards both new and existing investors for their unwavering trust in the organization's business model and strategic direction. Concurrently, the company remains engaged in a tender offer concerning its outstanding senior secured bonds, which are set to conclude on May 20, 2025. The results of this tender offer will be disclosed through an official press release shortly thereafter.

In collaboration with Nordea Bank Abp as the sole arranger and bookrunner for the bond issuance, as well as the dealer manager and tender agent for the ongoing tender offer, ADDvise continues to solidify its position in the life science sector. Legal guidance for these transactions was provided by Gernandt & Danielsson. Through innovative financing strategies, ADDvise Group not only strengthens its operational capabilities but also fosters sustainable growth across its decentralized network of over 20 companies operating in laboratory and healthcare sectors.

By embracing proactive financial management and leveraging investor confidence, ADDvise Group exemplifies how strategic planning can lead to robust organizational resilience. Such initiatives pave the way for continued innovation and expansion within the dynamic landscape of the life sciences industry, underscoring the importance of adaptability and foresight in achieving long-term success.

Related Articles